Small nucleolar RNA 42 acts as an oncogene in lung tumorigenesis
- PMID: 21986946
- PMCID: PMC4966663
- DOI: 10.1038/onc.2011.449
Small nucleolar RNA 42 acts as an oncogene in lung tumorigenesis
Abstract
Non-small cell lung cancer (NSCLC) is the leading cause of cancer death, reflecting the need for better understanding the oncogenesis, and developing new diagnostic and therapeutic targets for the malignancy. Emerging evidence suggests that small nucleolar RNAs (snoRNAs) have malfunctioning roles in tumorigenesis. Our recent study demonstrated that small nucleolar RNA 42 (SNORA42) was overexpressed in lung tumors. Here, we investigate the role of SNORA42 in tumorigenesis of NSCLC. We simultaneously assess genomic dosages and expression levels of SNORA42 and its host gene, KIAA0907, in 10 NSCLC cell lines and a human bronchial epithelial cell line. We then determine in vitro functional significance of SNORA42 in lung cancer cell lines through gain- and loss-of-function analyses. We also inoculate cancer cells with SNORA42-siRNA into mice through either tail vein or subcutaneous injection. We finally evaluate expression level of SNORA42 on frozen surgically resected lung tumor tissues of 64 patients with stage I NSCLC by using quantitative reverse transcriptase PCR assay. Genomic amplification and associated high expression of SNORA42 rather than KIAA0907 are frequently observed in lung cancer cells, suggesting that SNORA42 overexpression is activated by its genomic amplification. SNORA42 knockdown in NSCLC cells inhibits in vitro and in vivo tumorigenicity, whereas enforced SNORA42 expression in bronchial epitheliums increases cell growth and colony formation. Such pleiotropy of SNORA42 suppression could be achieved at least partially through increased apoptosis of NSCLC cells in a p53-dependent manner. SNORA42 expression in lung tumor tissue specimens is inversely correlated with survival of NSCLC patients. Therefore, SNORA42 activation could have an oncogenic role in lung tumorigenesis and provide potential diagnostic and therapeutic targets for the malignancy.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Small nucleolar RNA signatures of lung tumor-initiating cells.Mol Cancer. 2014 May 6;13:104. doi: 10.1186/1476-4598-13-104. Mol Cancer. 2014. PMID: 24886050 Free PMC article.
-
Clinical significance of SNORA42 as an oncogene and a prognostic biomarker in colorectal cancer.Gut. 2017 Jan;66(1):107-117. doi: 10.1136/gutjnl-2015-309359. Epub 2015 Oct 15. Gut. 2017. PMID: 26475630 Free PMC article.
-
Long non-coding RNA CARLo-5 is a negative prognostic factor and exhibits tumor pro-oncogenic activity in non-small cell lung cancer.Tumour Biol. 2014 Nov;35(11):11541-9. doi: 10.1007/s13277-014-2442-7. Epub 2014 Aug 17. Tumour Biol. 2014. PMID: 25129441
-
Small nucleolar RNAs in cancer.Biochim Biophys Acta. 2012 Aug;1826(1):121-8. doi: 10.1016/j.bbcan.2012.03.005. Epub 2012 Apr 3. Biochim Biophys Acta. 2012. PMID: 22498252 Free PMC article. Review.
-
The crucial roles of long noncoding RNA SNHGs in lung cancer.Clin Transl Oncol. 2022 Dec;24(12):2272-2284. doi: 10.1007/s12094-022-02909-5. Epub 2022 Aug 25. Clin Transl Oncol. 2022. PMID: 36008615 Review.
Cited by
-
Advances in the mechanism of small nucleolar RNA and its role in DNA damage response.Mil Med Res. 2024 Aug 8;11(1):53. doi: 10.1186/s40779-024-00553-4. Mil Med Res. 2024. PMID: 39118131 Free PMC article. Review.
-
SnoRNA U50A mediates everolimus resistance in breast cancer through mTOR downregulation.Transl Oncol. 2024 Oct;48:102062. doi: 10.1016/j.tranon.2024.102062. Epub 2024 Aug 1. Transl Oncol. 2024. PMID: 39094511 Free PMC article.
-
Small Nucleolar RNAs as Diagnostic and Prognostic Biomarkers in Cancer: A Systematic Review and Meta-Analysis.Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241245939. doi: 10.1177/15330338241245939. Technol Cancer Res Treat. 2024. PMID: 38752263 Free PMC article.
-
Fuzzy kernel evidence Random Forest for identifying pseudouridine sites.Brief Bioinform. 2024 Mar 27;25(3):bbae169. doi: 10.1093/bib/bbae169. Brief Bioinform. 2024. PMID: 38622357 Free PMC article.
-
Small nucleolar RNA and its potential role in the oncogenesis and development of colorectal cancer.World J Gastroenterol. 2024 Jan 14;30(2):115-127. doi: 10.3748/wjg.v30.i2.115. World J Gastroenterol. 2024. PMID: 38312115 Free PMC article. Review.
References
-
- Albertson DG, Ylstra B, Segraves R, Collins C, Dairkee SH, Kowbel D, et al. Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene. Nat Genet. 2000;25:144–146. - PubMed
-
- Baek SJ, Kim KS, Nixon JB, Wilson LC, Eling TE. Cyclooxygenase inhibitors regulate the expression of a TGF-â superfamily member that has proapoptotic and antitumorigenic activities. Mol Pharmacol. 2001;59:901–908. - PubMed
-
- Chang LS, Lin SY, Lieu AS, Wu TL. Differential expression of human 5S snoRNA genes. Biochem Biophys Res Commun. 2002;299:196–200. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous